---
title: è«è¾¾è²å°¼
description: 
published: true
date: 2026-01-29T16:33:37.433Z
tags: 
editor: markdown
dateCreated: 2026-01-26T13:10:46.495Z
---

# è«è¾¾éå°¼ (Modafinil)

[â—€è¿”å›](./home.md)


| **è«è¾¾éå°¼ (Modafinil)** | |
| --- | --- |
| [![Modafinil.svg](../æ–‡ä»¶/Modafinil.svg)](../æ–‡ä»¶/Modafinil.svg) | |
| **åŒ–å­¦å‘½å** | |
| **é€šç”¨åç§°** | *Modafinil, Alertec, Modavigil, Modiodal, Provigil, Modalert* |
| **å–ä»£åç§°** | *Modafinil* |
| **ç³»ç»Ÿåç§°** | *2-[(Diphenylmethyl)sulfinyl]acetamide* |
| **åˆ†ç±»å½’å±** | |
| **ç²¾ç¥æ´»æ€§åˆ†ç±»** | *[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) / [è§‰é†’å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§‰é†’å‰‚.md)* |
| **åŒ–å­¦åˆ†ç±»** | *[äºŒè‹¯ç”²åŸºç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/äºŒè‹¯ç”²åŸºç±»ç‰©è´¨.md)* |
| **[ç»™è¯é€”å¾„](../æ–‡æ¡£/ç»™è¯é€”å¾„.md)** | |
| - **è­¦å‘Šï¼š** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œä¸ªäººæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»ä½å‰‚é‡å¼€å§‹ã€‚[å‚é˜…è´Ÿè´£ä»»çš„ç”¨è¯éƒ¨åˆ†](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚ | â‡£ [å£æœ](../æ–‡æ¡£/ç»™è¯é€”å¾„.md#å£æœ) |
| **[ç»™è¯å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md)** | |
| [é˜ˆå€¼](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#é˜ˆå€¼) | 25 mg |
| [è½»å¾®](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#è½»å¾®) | 50 - 100 mg |
| [ä¸­ç­‰](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸­ç­‰) | 100 - 200 mg |
| [å¼ºçƒˆ](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#å¼ºçƒˆ) | 200 - 300 mg |
| [ä¸¥é‡](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md#ä¸¥é‡) | 300 mg + |
| **[è¯æ•ˆæ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md)** | |
| [æ€»æ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#æ€»æ—¶é•¿) | 5 - 10 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆå‘ä½œ) | 20 - 60 åˆ†é’Ÿ |
| [è¯æ•ˆä¸Šå‡](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆä¸Šå‡) | 20 - 60 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆè¾¾å³°) | 3.5 - 5 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆè¤ªå») | 1 - 3 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md#è¯æ•ˆæ®‹ä½™) | 2 - 6 å°æ—¶ |
| - **[å…è´£å£°æ˜](../æ–‡æ¡£/å…è´£å£°æ˜.md)ï¼š** æœ¬ç«™çš„[ç»™è¯å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md)ä¿¡æ¯æ”¶é›†è‡ªç”¨æˆ·å’Œ[ç›¸å…³èµ„æº](../æ–‡æ¡£/ç½‘ç»œèµ„æº.md)ï¼Œä»…ä¾›æ•™è‚²ç›®çš„ã€‚è¿™å¹¶éåŒ»ç–—å»ºè®®ï¼Œåº”é€šè¿‡å…¶ä»–æ¥æºæ ¸å®å‡†ç¡®æ€§ã€‚ | |
| **[ç›¸äº’ä½œç”¨](#å±é™©è¯ç‰©è”ç”¨)** | |
| [é…’ç²¾](../è¯ç‰©/é…’ç²¾.md) | âš ï¸ **è°¨æ…è”ç”¨** |
| [MXE](../è¯ç‰©/MXE.md) | ğŸ’” **è”ç”¨å±é™©** |
| [è§£ç¦»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§£ç¦»å‰‚.md) | ğŸ’” **è”ç”¨å±é™©** |
| [å³ç¾æ²™èŠ¬](../è¯ç‰©/å³ç¾æ²™èŠ¬.md) | âš ï¸ **è°¨æ…è”ç”¨** |
| [MDMA](../è¯ç‰©/MDMA.md) | âš ï¸ **è°¨æ…è”ç”¨** |
| [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) | ğŸ’” **è”ç”¨å±é™©** |
| [25x-NBOMe](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/N-è‹„åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) | ğŸ’” **è”ç”¨å±é™©** |
| [25x-NBOH](../è¯ç‰©/25x-NBOH.md) | ğŸ’” **è”ç”¨å±é™©** |
| [æ›²é©¬å¤š](../è¯ç‰©/æ›²é©¬å¤š.md) | ğŸ’” **è”ç”¨å±é™©** |
| [å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md) | âš ï¸ **è°¨æ…è”ç”¨** |
| [æ¿€ç´ é¿å­•è¯](../è¯ç‰©/æ¿€ç´ é¿å­•è¯.md) | âš ï¸ **è°¨æ…è”ç”¨** |
| CYP2C19åº•ç‰© | âš ï¸ **è°¨æ…è”ç”¨** |

**è«è¾¾éå°¼**ï¼ˆModafinilï¼Œä¹Ÿä»¥å•†å“å **Provigil**ã€**Alertec**ã€**Modavigil** ç­‰ä¸ºäººæ‰€çŸ¥ï¼‰æ˜¯[äºŒè‹¯ç”²åŸº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/äºŒè‹¯ç”²åŸºç±»ç‰©è´¨.md)ç±»[è§‰é†’å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§‰é†’å‰‚.md)ç‰©è´¨ï¼Œåœ¨[ç»™è¯](../æ–‡æ¡£/ç»™è¯é€”å¾„.md)æ—¶äº§ç”Ÿ[ä¿ƒé†’](../è¯æ•ˆ/æ¸…é†’åº¦å¢å¼º.md)å’Œ[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æ•ˆåº”ã€‚å®ƒé€šå¸¸åœ¨åŒ»ç–—å’ŒéåŒ»ç–—ç¯å¢ƒä¸­ç”¨äºå¢å¼ºè®¤çŸ¥ã€å‡å°‘ç–²åŠ³å’Œæé«˜è­¦è§‰æ€§ã€‚

è«è¾¾éå°¼å·²è¢«ç¾å›½é£Ÿå“è¯å“ç›‘ç£ç®¡ç†å±€æ‰¹å‡†ç”¨äºæ²»ç–—é˜»å¡æ€§ç¡çœ å‘¼å¸æš‚åœã€è½®ç­å·¥ä½œç¡çœ éšœç¢å’Œå‘ä½œæ€§ç¡ç—…ã€‚[\[1\]](#cite_note-1) ç„¶è€Œï¼Œç ”ç©¶è¡¨æ˜è«è¾¾éå°¼å¯èƒ½åœ¨æ ‡ç­¾å¤–ç”¨é€”ï¼ˆoff-labelï¼‰ä¸Šæœ‰åŠ©äºç¼“è§£æŠ‘éƒç—‡ã€[\[2\]](#cite_note-2) åŒç›¸æƒ…æ„Ÿéšœç¢ã€[\[3\]](#cite_note-3) å¸•é‡‘æ£®ç—…ã€[\[4\]](#cite_note-4) å­£èŠ‚æ€§æŠ‘éƒç—‡ã€[\[5\]](#cite_note-5) ADHDã€[\[6\]](#cite_note-6) ä»¥åŠå…¶ä»–å„ç§ä»¥ç–²åŠ³ä¸ºç—‡çŠ¶çš„ç–¾ç—…ã€‚

ç”±äºå…¶äº§ç”Ÿ[èº¯ä½“åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)çš„èƒ½åŠ›ï¼Œè«è¾¾éå°¼ä¹Ÿè¢«å„ç§è¿åŠ¨å‘˜ç”¨ä½œå…´å¥‹å‰‚ã€‚[\[7\]](#cite_note-7)[\[8\]](#cite_note-8)[\[9\]](#cite_note-9) å®ƒä½œä¸ºä¸€ç§â€œèªæ˜è¯â€ ï¼ˆ[ç›Šæ™ºè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç›Šæ™ºè¯.md)ï¼‰è¿‘æœŸåœ¨ä¸»æµç¤¾ä¼šè·å¾—äº†æ™®åŠï¼Œç”¨äº[æ”¹å–„è®°å¿†](../è¯æ•ˆ/è®°å¿†å¢å¼º.md)ã€å¯¹æŠ—ç¡çœ æ¬²æœ›æˆ–éœ€æ±‚ä»¥åŠæé«˜æ•´ä½“ç”Ÿäº§åŠ›ã€‚[\[10\]](#cite_note-10)

## ç›®å½•

* [1 å†å²ä¸æ–‡åŒ–](#å†å²ä¸æ–‡åŒ–)
* [2 åŒ–å­¦](#åŒ–å­¦)
* [3 è¯•å‰‚æµ‹è¯•é¢œè‰²ç»“æœ](#è¯•å‰‚æµ‹è¯•é¢œè‰²ç»“æœ)
* [4 è¯ç†å­¦](#è¯ç†å­¦)
* [5 ä¸»è§‚æ•ˆåº”](#ä¸»è§‚æ•ˆåº”)
    * [5.1 èº¯ä½“æ•ˆåº”](#èº¯ä½“æ•ˆåº”)
    * [5.2 è®¤çŸ¥æ•ˆåº”](#è®¤çŸ¥æ•ˆåº”)
    * [5.3 ä½“éªŒæŠ¥å‘Š](#ä½“éªŒæŠ¥å‘Š)
* [6 æ¯’æ€§ä¸ä¼¤å®³æ½œèƒ½](#æ¯’æ€§ä¸ä¼¤å®³æ½œèƒ½)
    * [6.1 è‡´æ­»å‰‚é‡](#è‡´æ­»å‰‚é‡)
    * [6.2 è€å—æ€§ä¸æˆç˜¾æ½œèƒ½](#è€å—æ€§ä¸æˆç˜¾æ½œèƒ½)
    * [6.3 å±é™©è¯ç‰©è”ç”¨](#å±é™©è¯ç‰©è”ç”¨)
* [7 æ³•å¾‹åœ°ä½](#æ³•å¾‹åœ°ä½)
* [8 å¦è§](#å¦è§)
* [9 å¤–éƒ¨é“¾æ¥](#å¤–éƒ¨é“¾æ¥)
* [10 å‚è€ƒæ–‡çŒ®](#å‚è€ƒæ–‡çŒ®)

## å†å²ä¸æ–‡åŒ–

è«è¾¾éå°¼æœ€åˆç”±ç¥ç»ç”Ÿç†å­¦æ•™æˆ Michel Jouvet å’Œ Lafon å®éªŒå®¤åœ¨æ³•å›½å¼€å‘ã€‚è«è¾¾éå°¼èµ·æºäº 20 ä¸–çºª 70 å¹´ä»£æœ«ä¸€ç³»åˆ—äºŒè‹¯ç”²åŸºäºšç¡«é…°åŸºåŒ–åˆç‰©çš„å‘æ˜ï¼Œå…¶ä¸­åŒ…æ‹¬é˜¿å¾·æ‹‰éå°¼ï¼ˆAdrafinilï¼‰ï¼Œè¯¥è¯äº 1986 å¹´åœ¨æ³•å›½é¦–æ¬¡ä½œä¸ºå‘ä½œæ€§ç¡ç—…çš„å®éªŒæ€§æ²»ç–—è¯ç‰©æ¨å‡ºã€‚è«è¾¾éå°¼æ˜¯[é˜¿å¾·æ‹‰éå°¼](../è¯ç‰©/é˜¿å¾·æ‹‰éå°¼.md)çš„ä¸»è¦ä»£è°¢äº§ç‰©ï¼Œå…¶æœ«ç«¯é…°èƒºä¸Šç¼ºå°‘ææ€§ -OH åŸºå›¢ï¼Œ[\[11\]](#cite_note-11) ä¸”å…·æœ‰ä¸å…¶æ¯ä½“è¯ç‰©ç›¸ä¼¼çš„æ´»æ€§ï¼Œä½†ä½¿ç”¨æ›´ä¸ºå¹¿æ³›ã€‚è‡ª 1994 å¹´ä»¥æ¥ï¼Œå®ƒåœ¨æ³•å›½ä»¥ Modiodal çš„åç§°å¤„æ–¹ä½¿ç”¨ï¼Œè‡ª 1998 å¹´ä»¥æ¥åœ¨ç¾å›½ä»¥ Provigil çš„åç§°å¤„æ–¹ä½¿ç”¨ã€‚

## åŒ–å­¦

è«è¾¾éå°¼æ˜¯[äºŒè‹¯ç”²åŸº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/äºŒè‹¯ç”²åŸºç±»ç‰©è´¨.md)ç±»çš„åˆæˆåˆ†å­ã€‚äºŒè‹¯ç”²åŸºåŒ–åˆç‰©ç”±è¿æ¥åˆ°å•ä¸ªç¢³åˆ†å­çš„ä¸¤ä¸ªè‹¯ç¯ç»„æˆã€‚è«è¾¾éå°¼è¢«å½’ç±»ä¸ºäºšç¡«é…°åŸºäºŒè‹¯ç”²åŸºåˆ†å­ï¼Œå› ä¸ºå®ƒè¿˜åŒ…å«ä¸€ä¸ªäºšç¡«é…°åŸºå›¢ï¼Œå³ä¸€ä¸ªç¡«åˆ†å­ä¸ä¸€ä¸ªæ°§åˆ†å­åŒé”®ç»“åˆï¼Œè¿æ¥åˆ°äºŒè‹¯ç”²åŸºåŸºå›¢çš„ç¢³ä¸Šã€‚ä» R2 å¤„çš„è¿™ä¸ªç¡«åŸºå›¢ï¼Œä¸€ä¸ªä¹™é…°èƒºåŸºå›¢é€šè¿‡ä¸€ä¸ªç¾°åŸºè¿æ¥åˆ°å…¶æ¸¸ç¦»ç¢³ä¸Šçš„æœ«ç«¯èƒºåŸºå›¢ã€‚è«è¾¾éå°¼åœ¨ç»“æ„ä¸Šç±»ä¼¼äºæ°Ÿæ‹‰éå°¼ï¼ˆFluorafinilï¼‰ï¼Œå¦ä¸€ç§äºŒè‹¯ç”²åŸºå…´å¥‹å‰‚ã€‚

è™½ç„¶è«è¾¾éå°¼æ˜¯å¤–æ¶ˆæ—‹æ··åˆç‰©ï¼Œä½†ç±»ä¼¼çš„è¯ç‰©[é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)ä»…åŒ…å«è«è¾¾éå°¼çš„ (âˆ’)-(R)-å¯¹æ˜ ä½“ã€‚è«è¾¾éå°¼æ˜¯ä¸€ç§ç»è¿‡é«˜åº¦ç ”ç©¶çš„åŒ–åˆç‰©ï¼Œå·²åˆ›é€ å¹¶ç ”ç©¶äº†è®¸å¤šè¡ç”Ÿç‰©[\[12\]](#cite_note-12)ã€‚

## è¯•å‰‚æµ‹è¯•é¢œè‰²ç»“æœ

è¦äº†è§£æŸç§ç‰©è´¨æ˜¯å¦å¯èƒ½æ˜¯è«è¾¾éå°¼ï¼Œå¯ä»¥ä½¿ç”¨è¯•å‰‚æµ‹è¯•å¥—ä»¶ã€‚å¯¹åŒä¸€ç‰©è´¨åº”ç”¨ä¸åŒçš„è¯•å‰‚å¯èƒ½ä¼šå¯¼è‡´ç‰¹å®šçš„é¢œè‰²å˜åŒ–ã€‚ä¸‹å›¾ä¸­æ˜¾ç¤ºäº†è«è¾¾éå°¼åœ¨å„è‡ªè¯•å‰‚æµ‹è¯•ï¼ˆMarquisã€Meckeã€Mandelinã€Liebermann å’Œ Froehdeï¼‰ä¸­çš„é¢„æœŸé¢œè‰²å˜åŒ–ã€‚å°†ç‰©è´¨æš´éœ²äºè¯•å‰‚å¯èƒ½ä¼šå¼•èµ·é¢œè‰²å˜åŒ–ï¼Œè¿™è¡¨æ˜æ­£åœ¨æµ‹è¯•çš„ç‰©è´¨ [\[13\]](#cite_note-13) ã€‚è¯•å‰‚æµ‹è¯•ä¸èƒ½ä¿è¯ç‰©è´¨æ˜¯çº¯å‡€çš„ã€‚è¦æµ‹è¯•ç‰©è´¨çš„çº¯åº¦ï¼Œè¯·è€ƒè™‘è–„å±‚è‰²è°±æ³• (TLC) ç”šè‡³æ›´å¤æ‚çš„æµ‹è¯•ï¼Œå¦‚æ°”ç›¸è‰²è°±æ³•ã€‚

[![](../æ–‡ä»¶/Modafinil-reagent-colors-psychonautwiki.svg)](../æ–‡ä»¶/Modafinil-reagent-colors-psychonautwiki.svg)

è«è¾¾éå°¼çš„é¢„æœŸé¢œè‰²å˜åŒ–

## è¯ç†å­¦

[![](../æ–‡ä»¶/Rsmodafinil-moa.svg)](../æ–‡ä»¶/Rsmodafinil-moa.svg)

(R,S)-è«è¾¾éå°¼ï¼Œä½œç”¨æœºåˆ¶ã€‚

å°½ç®¡è«è¾¾éå°¼åŠå…¶ R-å¯¹æ˜ ä½“[é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)å‡å°‘å—œç¡çš„ç¡®åˆ‡æœºåˆ¶å°šä¸å®Œå…¨æ¸…æ¥šï¼Œä½†è¯æ®è¡¨æ˜è¿™äº›è¯ç‰©é€šè¿‡ç›´æ¥æˆ–é—´æ¥ä½œç”¨äºç¡çœ /è§‰é†’å›è·¯çš„è®¸å¤šç»„æˆéƒ¨åˆ†æ¥ä¿ƒè¿›è§‰é†’ã€‚æ®æ¨æµ‹ï¼Œè«è¾¾éå°¼å’Œ[é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)å¯æŠ‘åˆ¶ [GABA](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/GABA.md) å¹¶ä¿ƒè¿› [å¤šå·´èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¤šå·´èƒº.md)ã€[å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å»ç”²è‚¾ä¸Šè…ºç´ .md)ã€[ç»„èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç»„èƒº.md)å’Œé£Ÿæ¬²ç´ /é˜¿ç«‹æ–°ï¼ˆorexinï¼‰ã€‚[\[14\]](#cite_note-morrissette2013-14)[\[15\]](#cite_note-15)[\[16\]](#cite_note-darwish2012-16)[\[17\]](#cite_note-17)

è«è¾¾éå°¼åŠå…¶ R-å¯¹æ˜ ä½“[é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)å¯å¢åŠ [å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å»ç”²è‚¾ä¸Šè…ºç´ .md) (NE) å’Œ[å¤šå·´èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¤šå·´èƒº.md) (DA)ï¼Œè¿™å¯èƒ½æ˜¯é€šè¿‡å®ƒä»¬é˜»æ–­ NE å’Œ DA å†æ‘„å–è½¬è¿è›‹ç™½ï¼ˆåˆ†åˆ«ä¸º NET å’Œ DATï¼‰æ¥å®ç°çš„ã€‚NE åœ¨ Î±-è‚¾ä¸Šè…ºç´ èƒ½å—ä½“ä¸Šçš„ä½œç”¨å’Œ DA åœ¨[å¤šå·´èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¤šå·´èƒº.md) D2 å—ä½“ä¸Šçš„ä½œç”¨è¢«è®¤ä¸ºæœ‰åŠ©äºè«è¾¾éå°¼çš„ä¿ƒé†’ç‰¹æ€§ã€‚é£Ÿæ¬²ç´ æ˜¯è§‰é†’ç³»ç»Ÿçš„å…³é”®ç»„æˆéƒ¨åˆ†ï¼›å› æ­¤ï¼Œè«è¾¾éå°¼å¯¹é£Ÿæ¬²ç´ ç³»ç»Ÿçš„æ¨æµ‹ä½œç”¨å¯èƒ½æœ‰åŠ©äºæé«˜è­¦è§‰æ€§ã€‚æ­¤å¤–ï¼Œè«è¾¾éå°¼å¯èƒ½é€šè¿‡å‡å°‘ GABA èƒ½å¯¹ç»„èƒºèƒ½ç¥ç»å…ƒçš„æŠ‘åˆ¶æˆ–é€šè¿‡ä½œç”¨äºé£Ÿæ¬²ç´ èƒ½ç¥ç»å…ƒæ¥é—´æ¥å¢åŠ ç»„èƒºã€‚ [ç»„èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç»„èƒº.md)çš„å¢åŠ å¯èƒ½æœ‰åŠ©äºè«è¾¾éå°¼çš„ä¿ƒé†’ä½œç”¨ä»¥åŠè«è¾¾éå°¼æé«˜è­¦è§‰æ€§çš„æ½œåŠ›ã€‚[\[14\]](#cite_note-morrissette2013-14)[\[16\]](#cite_note-darwish2012-16)[\[18\]](#cite_note-18)

åœ¨ç¼ºä¹å¤šå·´èƒºè½¬è¿è›‹ç™½ (DAT) çš„åŸºå› å·¥ç¨‹å°é¼ ä¸­ï¼Œè«è¾¾éå°¼ç¼ºä¹ä¿ƒé†’æ´»æ€§ï¼Œè¿™è¡¨æ˜è¿™ç§æ´»æ€§æ˜¯ DAT ä¾èµ–æ€§çš„ã€‚ç„¶è€Œï¼Œä¸[è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)ä¸åŒï¼Œè«è¾¾éå°¼çš„ä¿ƒé†’ä½œç”¨å¹¶æ²¡æœ‰è¢«å¤§é¼ ä¸­çš„å¤šå·´èƒºå—ä½“[æ‹®æŠ—å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æ‹®æŠ—å‰‚.md)[æ°Ÿå“Œå•¶é†‡](../è¯ç‰©/æ°Ÿå“Œå•¶é†‡.md)é™ä½ã€‚æ­¤å¤–ï¼ŒÎ±-ç”²åŸº-å¯¹-é…ªæ°¨é…¸ï¼ˆä¸€ç§å¤šå·´èƒºåˆæˆæŠ‘åˆ¶å‰‚ï¼‰å¯é˜»æ–­è‹¯ä¸™èƒºçš„ä½œç”¨ï¼Œä½†ä¸ä¼šé˜»æ–­è«è¾¾éå°¼å¼•èµ·çš„è¿åŠ¨æ´»æ€§ã€‚

## ä¸»è§‚æ•ˆåº”

ä¸ä¼ ç»Ÿçš„å…´å¥‹å‰‚å¦‚[è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)ã€[å“Œç”²é…¯](../è¯ç‰©/å“Œç”²é…¯.md)æˆ–[å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md)ç›¸æ¯”ï¼Œè¯¥åŒ–åˆç‰©å¼•èµ·çš„ä½“éªŒåœ¨å¼ºçƒˆç¨‹åº¦ã€æ¬£å¿«æ„Ÿå’Œå¨±ä¹æ€§æ–¹é¢è¦ä½å¾—å¤šã€‚å®ƒåè€Œå¼ºè°ƒä¸€èˆ¬çš„[æ¸…é†’åº¦](../è¯æ•ˆ/æ¸…é†’åº¦.md)å’Œ[åŠ¨æœºå¢å¼º](../è¯æ•ˆ/åŠ¨æœºå¢å¼º.md)ã€‚

***å…è´£å£°æ˜ï¼š**ä¸‹åˆ—æ•ˆåº”åˆ—å‡ºäº†[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](/è¯æ•ˆ/home.md) (**SEI**)ï¼Œè¿™æ˜¯åŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ [PsychonautWiki](../å…³äºæœ¬ç«™/home.md) [è´¡çŒ®è€…](../å…³äºæœ¬ç«™/home.md)çš„ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”ä»¥å¥åº·çš„æ€€ç–‘æ€åº¦çœ‹å¾…å®ƒä»¬ã€‚*

*åŒæ ·å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡é«˜å‰‚é‡æ›´å®¹æ˜“è¯±å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚*åŒæ ·ï¼Œ**ä¸è‰¯ååº”**éšç€å‰‚é‡çš„å¢åŠ å˜å¾—è¶Šæ¥è¶Šå¯èƒ½ï¼Œå¹¶ä¸”å¯èƒ½åŒ…æ‹¬**[æˆç˜¾](../æ–‡æ¡£/æˆç˜¾.md)ã€ä¸¥é‡ä¼¤å®³æˆ–[æ­»äº¡](../æ–‡æ¡£/æ­»äº¡.md)*** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”**

*   **[åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)** - å°±å…¶å¯¹ä½¿ç”¨è€…èº«ä½“èƒ½é‡æ°´å¹³çš„å½±å“è€Œè¨€ï¼Œè«è¾¾éå°¼é€šå¸¸è¢«è®¤ä¸ºæ˜¯å…·æœ‰åˆºæ¿€æ€§å’Œæ´»åŠ›çš„ï¼Œä½†ä¸[è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)ç›¸æ¯”ï¼Œå…¶åˆºæ¿€æ€§è¦å°å¾—å¤šã€‚è¿™ç§åˆºæ¿€é¼“åŠ±èº«ä½“è¿åŠ¨å’Œæ´»åŠ¨ï¼Œå¦‚è·‘æ­¥ã€è¿åŠ¨ã€ç¤¾äº¤å’Œ/æˆ–é”»ç‚¼ã€‚è«è¾¾éå°¼å‘ˆç°çš„ç‰¹å®šé£æ ¼çš„åˆºæ¿€å¯èƒ½å¯¼è‡´ä¸‹å·´ç´§å’¬ã€ç£¨ç‰™æˆ–å…¶ä»–ç±»ä¼¼äºé«˜å‰‚é‡ä¼ ç»Ÿå…´å¥‹å‰‚çš„ä¸è‡ªä¸»è¿åŠ¨ï¼Œä½†ä¸[è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)æˆ–[å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md)ç›¸æ¯”ï¼Œå…¶è¡¨ç°çš„ä¸€è‡´æ€§å’Œå¼ºåº¦è¦ä½å¾—å¤šã€‚
*   **[å¿ƒç‡å¢å¿«](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)**\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/æ¥æºè¯·æ±‚.md)*\]
*   **[é£Ÿæ¬²æŠ‘åˆ¶](../è¯æ•ˆ/é£Ÿæ¬²æŠ‘åˆ¶.md)** - ä¸Šè¿°æˆåˆ†ä¹Ÿä¼´éšç€é£Ÿæ¬²çš„æŠ‘åˆ¶ï¼Œä¸[è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)æ‰€ç»å†çš„é£Ÿæ¬²æŠ‘åˆ¶ç›¸æ¯”ï¼Œå…¶å¼ºåº¦é€šå¸¸è¾ƒå¼±ã€‚
*   **[è„±æ°´](../è¯æ•ˆ/è„±æ°´.md)** - è„±æ°´å’Œ[å£å¹²](../è¯æ•ˆ/å£å¹².md)é€šå¸¸å‘ç”Ÿï¼Œè¿™æ˜¯ç”±äºä»äº‹ä½“è‚²æ´»åŠ¨çš„åŠ¨æœºå¢åŠ ä»¥åŠä¸“æ³¨æ„Ÿå¢å¼ºå¯¼è‡´å¿˜è®°å–æ°´ã€‚
*   **[å¤´ç—›](../è¯æ•ˆ/å¤´ç—›.md)** - åœ¨èº«ä½“ä¸é€‚æ–¹é¢ï¼Œè«è¾¾éå°¼å¯èƒ½ä¼šå¯¼è‡´å¤´ç—›ï¼Œå°¤å…¶æ˜¯åœ¨è„±æ°´ã€æœªè¿›é£Ÿæˆ–é•¿æ—¶é—´ä¿æŒå°´å°¬å§¿åŠ¿ä¸“æ³¨äºä»»åŠ¡çš„æƒ…å†µä¸‹ã€‚
*   **[ä½“å‘³æ”¹å˜](../è¯æ•ˆ/ä½“å‘³æ”¹å˜.md)** - è«è¾¾éå°¼ä¼šåœ¨å°¿æ¶²ä¸­ç•™ä¸‹éå¸¸æ˜æ˜¾çš„ç¡«ç£ºå‘³ã€‚è¿™å¯èƒ½æ˜¯å› ä¸ºè«è¾¾éå°¼ä½œä¸ºäºšç¡«é…°åŸºäºŒè‹¯ç”²åŸºåŒ–å­¦ç±»åˆ«çš„æˆå‘˜ï¼Œåœ¨å…¶åŒ–å­¦ç»„æˆä¸­å«æœ‰ç¡«ã€‚[\[19\]](#cite_note-19)
*   **[ç³å­”æ‰©å¤§](../è¯æ•ˆ/ç³å­”æ‰©å¤§.md)**
*   **[ç•å…‰](../è¯æ•ˆ/ç•å…‰.md)** - è™½ç„¶ä¸å¸¸è§ï¼Œä½†è«è¾¾éå°¼å¯èƒ½ä¼šå¯¼è‡´æš‚æ—¶çš„è§†è§‰å…‰ä¸è€å—ã€‚
*   **[å¤´æ™•](../è¯æ•ˆ/å¤´æ™•.md)**
*   **[æ¶å¿ƒ](../è¯æ•ˆ/æ¶å¿ƒ.md)**
*   **[è…¹æ³»](../è¯æ•ˆ/è…¹æ³».md)**

### **è®¤çŸ¥æ•ˆåº”**

*   **[æ¸…é†’åº¦](../è¯æ•ˆ/æ¸…é†’åº¦.md)**
*   **[ä¸“æ³¨åº¦å¢å¼º](../è¯æ•ˆ/ä¸“æ³¨åº¦å¢å¼º.md)**
*   **[æŠ‘éƒå‡è½»](../è¯æ•ˆ/æŠ‘éƒå‡è½».md)**
*   **[æ€ç»´åŠ é€Ÿ](../è¯æ•ˆ/æ€ç»´åŠ é€Ÿ.md)**
*   **[è®°å¿†å¢å¼º](../è¯æ•ˆ/è®°å¿†å¢å¼º.md)**
*   **[åŠ¨æœºå¢å¼º](../è¯æ•ˆ/åŠ¨æœºå¢å¼º.md)**
*   **[æ—¶é—´æ‰­æ›²](../è¯æ•ˆ/æ—¶é—´æ‰­æ›².md)**
*   **[æƒ…ç»ªå¢å¼º](../è¯æ•ˆ/æƒ…ç»ªå¢å¼º.md)** æˆ– **[æƒ…ç»ªæŠ‘åˆ¶](../è¯æ•ˆ/æƒ…ç»ªæŠ‘åˆ¶.md)**
*   **[ç„¦è™‘](../è¯æ•ˆ/ç„¦è™‘.md)** æˆ– **[ç„¦è™‘æŠ‘åˆ¶](../è¯æ•ˆ/ç„¦è™‘æŠ‘åˆ¶.md)**\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/æ¥æºè¯·æ±‚.md)*\]
*   **[éŸ³ä¹æ¬£èµå¢å¼º](../è¯æ•ˆ/éŸ³ä¹æ¬£èµå¢å¼º.md)** - è™½ç„¶è«è¾¾éå°¼èƒ½å¤Ÿäº§ç”Ÿè¿™ç§æ•ˆæœï¼Œä½†å®ƒå¹¶ä¸åƒä¼ ç»Ÿ[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æˆ–[å…±æƒ…å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)é‚£æ ·å¯é ã€‚

### ä½“éªŒæŠ¥å‘Š

ç›®å‰åœ¨æˆ‘ä»¬çš„[ä½“éªŒç´¢å¼•](../æ–‡æ¡£/ä½“éªŒç´¢å¼•.md)ä¸­æ²¡æœ‰æè¿°è¯¥åŒ–åˆç‰©æ•ˆåº”çš„è½¶äº‹æŠ¥å‘Šã€‚å…¶ä»–çš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

*   [Erowid Experience Vaults: Modafinil](https://www.erowid.org/experiences/subs/exp_Modafinil.shtml)

## æ¯’æ€§ä¸ä¼¤å®³æ½œèƒ½

è«è¾¾éå°¼ä½œä¸ºå¸¸è§„ä½¿ç”¨è¯ç‰©çš„é•¿æœŸå®‰å…¨æ€§å’Œæœ‰æ•ˆæ€§å°šæœªç¡®å®šã€‚[\[20\]](#cite_note-20)

å°è¯•è¿‡è«è¾¾éå°¼çš„äººçš„è½¶äº‹æŠ¥å‘Šè¡¨æ˜ï¼Œä»…ä»…å•ç‹¬ä»¥ä½è‡³ä¸­ç­‰å‰‚é‡å°è¯•è¿™ç§ç‰©è´¨æˆ–å°‘é‡ä½¿ç”¨ï¼ˆä½†æ²¡æœ‰ä»»ä½•äº‹æƒ…å¯ä»¥å®Œå…¨ä¿è¯ï¼‰ï¼Œä¼¼ä¹æ²¡æœ‰ä»»ä½•è´Ÿé¢çš„å¥åº·å½±å“ã€‚

å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œç”±äºè¯¥åŒ–åˆç‰©æ˜¯ä¸€ç§å¸¸ç”¨çš„å¤„æ–¹è¯ï¼Œä¸å…¸å‹çš„[ç ”ç©¶ç”¨åŒ–å­¦å“](../æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)ç›¸æ¯”ï¼Œå®ƒå‘ç”Ÿä¸å¯é¢„æµ‹çš„ä¸è‰¯å¥åº·å½±å“çš„å¯èƒ½æ€§è¦å°å¾—å¤šã€‚å°½ç®¡å¦‚æ­¤ï¼Œå¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œå¼ºçƒˆå»ºè®®é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚

### è‡´æ­»å‰‚é‡

è«è¾¾éå°¼å¯¹äººç±»çš„åŠæ•°è‡´æ­»å‰‚é‡ï¼ˆ[LD50](../æ–‡æ¡£/LD50.md)ï¼‰ä»æœªè¾¾åˆ°ã€‚åœ¨è¿ç»­ 7 åˆ° 21 å¤©æ¯å¤©ç»™äºˆ 1000mg åˆ° 1600mg è«è¾¾éå°¼çš„ä¸´åºŠè¯•éªŒä¸­ï¼Œæœªå‘ç”Ÿå±åŠç”Ÿå‘½çš„æ•ˆåº”ã€‚ä¸¤åæˆå¹´å—è¯•è€…åˆ†åˆ«æ•…æ„æ€¥æ€§è¿‡é‡æœç”¨ 4500mg å’Œ 4000mgï¼Œä»¥åŠä¸€åä¸‰å²å„¿ç«¥æ„å¤–æ‘„å…¥ 800mgï¼Œå‡æœªå¯¼è‡´ä»»ä½•å±åŠç”Ÿå‘½çš„æ•ˆåº”æˆ–æ­»äº¡ã€‚[\[21\]](#cite_note-21) ä¸€ååäº”å²å¥³æ€§åœ¨è‡ªæ€æœªé‚ä¸­è¿‡é‡æœç”¨ 5000mg è«è¾¾éå°¼åï¼ŒæŠ¥å‘Šäº†ä¸¥é‡çš„[å¤´ç—›](../è¯æ•ˆ/å¤´ç—›.md)ã€[æ¶å¿ƒ](../è¯æ•ˆ/æ¶å¿ƒ.md)å’Œ[å¿ƒåŠ¨è¿‡é€Ÿ](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)ï¼Œä½†ä¼¼ä¹æ²¡æœ‰ä»»ä½•è‡´å‘½æˆ–é•¿æœŸçš„å½±å“ã€‚[\[22\]](#cite_note-22)

### è€å—æ€§ä¸æˆç˜¾æ½œèƒ½

é•¿æœŸä½¿ç”¨è«è¾¾éå°¼å¯è¢«è§†ä¸ºæ— æˆç˜¾æ€§ï¼Œæ»¥ç”¨å¯èƒ½æ€§ä½ã€‚å®ƒä¼¼ä¹ä¸å¤ªèƒ½å¤Ÿåœ¨å¤§å¤šæ•°ä½¿ç”¨è€…ä¸­å¼•èµ·å¿ƒç†ä¾èµ–ã€‚\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/æ¥æºè¯·æ±‚.md)*\]

éšç€é•¿æœŸå’Œé‡å¤ä½¿ç”¨ï¼Œä¼šå¯¹è«è¾¾éå°¼çš„è®¸å¤šæ•ˆåº”äº§ç”Ÿè€å—æ€§ã€‚è¿™å¯¼è‡´ä½¿ç”¨è€…å¿…é¡»æœç”¨è¶Šæ¥è¶Šå¤§çš„å‰‚é‡æ‰èƒ½è¾¾åˆ°ç›¸åŒçš„æ•ˆæœã€‚ä¹‹åï¼Œè€å—æ€§å‡å°‘åˆ°ä¸€åŠå¤§çº¦éœ€è¦ 3 - 7 å¤©ï¼Œæ¢å¤åˆ°åŸºçº¿éœ€è¦ 1 - 2 å‘¨ï¼ˆåœ¨ä¸è¿›ä¸€æ­¥æ‘„å…¥çš„æƒ…å†µä¸‹ï¼‰ã€‚è«è¾¾éå°¼å¯èƒ½ä¸æ‰€æœ‰[äºŒè‹¯ç”²åŸº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/äºŒè‹¯ç”²åŸºç±»ç‰©è´¨.md)[ç›Šæ™ºè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç›Šæ™ºè¯.md)å­˜åœ¨äº¤å‰è€å—æ€§ï¼Œè¿™æ„å‘³ç€åœ¨æœç”¨è«è¾¾éå°¼åï¼Œæ‰€æœ‰ç›¸å…³çš„è§‰é†’å‰‚åŒ–åˆç‰©ï¼Œå¦‚[é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)å’Œ[é˜¿å¾·æ‹‰éå°¼](../è¯ç‰©/é˜¿å¾·æ‹‰éå°¼.md)ï¼Œå…¶æ•ˆæœéƒ½ä¼šé™ä½ã€‚

### å±é™©è¯ç‰©è”ç”¨

***è­¦å‘Šï¼š*** *è®¸å¤šç²¾ç¥æ´»æ€§ç‰©è´¨å•ç‹¬ä½¿ç”¨æ—¶ç›¸å¯¹å®‰å…¨ï¼Œä½†ä¸æŸäº›å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶å¯èƒ½ä¼šçªç„¶å˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä»¥ä¸‹åˆ—è¡¨æä¾›äº†ä¸€äº›å·²çŸ¥çš„å±é™©ç›¸äº’ä½œç”¨ï¼ˆå°½ç®¡ä¸ä¿è¯åŒ…æ‹¬æ‰€æœ‰ç›¸äº’ä½œç”¨ï¼‰ã€‚*

*åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶ï¼ˆä¾‹å¦‚ [Google](https://www.google.com)ã€[DuckDuckGo](https://www.duckduckgo.com)ã€[PubMed](https://pubmed.ncbi.nlm.nih.gov/)ï¼‰ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆå¯ä»¥å®‰å…¨é£Ÿç”¨ã€‚éƒ¨åˆ†åˆ—å‡ºçš„ç›¸äº’ä½œç”¨æ¥è‡ª [TripSit](https://combo.tripsit.me)ã€‚*

*   **[25x-NBOMe](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/N-è‹„åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) & [25x-NBOH](../è¯ç‰©/25x-NBOH.md)** - 25x åŒ–åˆç‰©å…·æœ‰é«˜åº¦åˆºæ¿€æ€§ï¼Œå¯¹èº«ä½“æœ‰å‹åŠ›ã€‚åº”ä¸¥æ ¼é¿å…ä¸è«è¾¾éå°¼è”ç”¨ï¼Œå› ä¸ºå­˜åœ¨è¿‡åº¦[åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)å’Œå¿ƒè„å‹åŠ›çš„é£é™©ã€‚è¿™å¯èƒ½å¯¼è‡´[è¡€å‹å‡é«˜](../è¯æ•ˆ/è¡€å‹å‡é«˜.md)ã€[è¡€ç®¡æ”¶ç¼©](../è¯æ•ˆ/è¡€ç®¡æ”¶ç¼©.md)ã€ææ…Œå‘ä½œã€[æ€ç»´å¾ªç¯](../è¯æ•ˆ/æ€ç»´å¾ªç¯.md)ã€[ç™«ç—«å‘ä½œ](../è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)ï¼Œæå°‘æ•°æƒ…å†µä¸‹ä¼šå¯¼è‡´å¿ƒåŠ›è¡°ç«­ã€‚
*   **[é…’ç²¾](../è¯ç‰©/é…’ç²¾.md)** - å°†é…’ç²¾ä¸[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æ··åˆæ˜¯å±é™©çš„ï¼Œå› ä¸ºå­˜åœ¨æ„å¤–è¿‡åº¦ä¸­æ¯’çš„é£é™©ã€‚å…´å¥‹å‰‚ä¼šæ©ç›–é…’ç²¾çš„[æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ä½œç”¨ï¼Œè€Œå¤§å¤šæ•°äººåˆ©ç”¨è¿™ç§ä½œç”¨æ¥è¯„ä¼°è‡ªå·±çš„é†‰é…’ç¨‹åº¦ã€‚ä¸€æ—¦å…´å¥‹å‰‚æ¶ˆé€€ï¼Œ[æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ä½œç”¨å°†ä¸å†å—å¯¹æŠ—ï¼Œè¿™å¯èƒ½å¯¼è‡´æ–­ç‰‡å’Œä¸¥é‡çš„[å‘¼å¸æŠ‘åˆ¶](../è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€‚å¦‚æœæ··åˆä½¿ç”¨ï¼Œä½¿ç”¨è€…åº”ä¸¥æ ¼é™åˆ¶è‡ªå·±æ¯å°æ—¶åªå–ä¸€å®šé‡çš„é…’ç²¾ã€‚
*   **[å³ç¾æ²™èŠ¬](../è¯ç‰©/å³ç¾æ²™èŠ¬.md)** - åº”é¿å…ä¸å³ç¾æ²™èŠ¬è”ç”¨ï¼Œå› ä¸ºå®ƒå¯¹[5-ç¾Ÿè‰²èƒº](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/5-ç¾Ÿè‰²èƒº.md)å’Œ[å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å»ç”²è‚¾ä¸Šè…ºç´ .md)çš„å†æ‘„å–æœ‰æŠ‘åˆ¶ä½œç”¨ã€‚ä¸5-ç¾Ÿè‰²èƒºé‡Šæ”¾å‰‚ï¼ˆ[MDMA](../è¯ç‰©/MDMA.md)ã€[ç”²åŸºé…®](../è¯ç‰©/ç”²åŸºé…®.md)ã€[ç”²æ°§éº»é»„é…®](../è¯ç‰©/ç”²æ°§éº»é»„é…®.md)ç­‰ï¼‰è”ç”¨ä¼šå¢åŠ [ææ…Œå‘ä½œ](../è¯æ•ˆ/ææ…Œå‘ä½œ.md)å’Œé«˜è¡€å‹å±è±¡ï¼Œæˆ–[è¡€æ¸…ç´ ç»¼åˆå¾](../æ–‡æ¡£/è¡€æ¸…ç´ ç»¼åˆå¾.md)çš„é£é™©ã€‚ä»”ç»†ç›‘æµ‹è¡€å‹å¹¶é¿å…å‰§çƒˆçš„ä½“è‚²æ´»åŠ¨ã€‚
*   **[MDMA](../è¯ç‰©/MDMA.md)** - å½“å­˜åœ¨å…¶ä»–[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)æ—¶ï¼ŒMDMA çš„ä»»ä½•ç¥ç»æ¯’æ€§æ•ˆåº”éƒ½å¯èƒ½ä¼šå¢åŠ ã€‚è¿˜å­˜åœ¨è¡€å‹è¿‡é«˜å’Œå¿ƒè„å‹åŠ›ï¼ˆå¿ƒè„æ¯’æ€§ï¼‰çš„é£é™©ã€‚
*   **[MXE](../è¯ç‰©/MXE.md)** - ä¸€äº›æŠ¥å‘Šè¡¨æ˜ï¼Œä¸ MXE è”ç”¨å¯èƒ½ä¼šå±é™©åœ°å¢åŠ è¡€å‹ï¼Œå¹¶å¢åŠ [èºç‹‚](../è¯æ•ˆ/èºç‹‚.md)å’Œ[ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md)çš„é£é™©ã€‚
*   **[è§£ç¦»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§£ç¦»å‰‚.md)** - è¿™ä¸¤ç±»è¯ç‰©éƒ½å¸¦æœ‰[å¦„æƒ³](../è¯æ•ˆ/å¦„æƒ³.md)ã€[èºç‹‚](../è¯æ•ˆ/èºç‹‚.md)å’Œ[ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md)çš„é£é™©ï¼Œè”ç”¨æ—¶è¿™äº›é£é™©å¯èƒ½ä¼šå€å¢ã€‚
*   **[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** - è«è¾¾éå°¼ä¸[å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md)ç­‰å…¶ä»–[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)è”ç”¨å¯èƒ½æ˜¯å±é™©çš„ï¼Œå› ä¸ºå®ƒä»¬ä¼šå°†[å¿ƒç‡](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)å’Œ[è¡€å‹](../è¯æ•ˆ/è¡€å‹å‡é«˜.md)æé«˜åˆ°å±é™©æ°´å¹³ã€‚
*   **[æ›²é©¬å¤š](../è¯ç‰©/æ›²é©¬å¤š.md)** - å·²çŸ¥æ›²é©¬å¤šä¼šé™ä½ç™«ç—«å‘ä½œé˜ˆå€¼ [\[23\]](#cite_note-23)ï¼Œä¸å…´å¥‹å‰‚è”ç”¨å¯èƒ½ä¼šè¿›ä¸€æ­¥å¢åŠ è¿™ç§é£é™©ã€‚
*   **[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)** - è¿™ç§ç»„åˆå¯èƒ½ä¼šå°†å¤šå·´èƒºç­‰ç¥ç»é€’è´¨çš„é‡å¢åŠ åˆ°å±é™©ç”šè‡³è‡´å‘½çš„æ°´å¹³ã€‚ä¾‹å¦‚[å™åˆ©äºšèŠ¸é¦™](../è¯ç‰©/å™åˆ©äºšèŠ¸é¦™.md)ã€[*å¡çš®æœ¨*](../è¯ç‰©/å¡çš®æœ¨.md)å’Œä¸€äº›[æŠ—æŠ‘éƒè¯](../è¯ç‰©/æŠ—æŠ‘éƒè¯.md)ã€‚[\[24\]](#cite_note-24)
*   **æ¿€ç´ é¿å­•è¯** - è«è¾¾éå°¼é€šè¿‡å¢åŠ é…¶ CYP3A4/5 çš„æ´»æ€§ï¼Œåœ¨ä½¿ç”¨åé•¿è¾¾ä¸€ä¸ªæœˆå†…ä¼šé™ä½æ¿€ç´ é¿å­•è¯çš„æœ‰æ•ˆæ€§ã€‚[\[25\]](#cite_note-25) å€¼å¾—æ³¨æ„çš„æ˜¯ï¼ŒåŒæ ·çš„é…¶ä¼šè¢«è‘¡è„æŸšæ±æŠ‘åˆ¶ã€‚[\[26\]](#cite_note-26)
*   **CYP2C19 åº•ç‰©** - è«è¾¾éå°¼å¯èƒ½ä¼šå»¶é•¿æŸäº›æŠ—ç„¦è™‘è¯å¦‚åœ°è¥¿æ³®ã€æ™®è˜æ´›å°”å’Œæ°¯ç±³å¸•æ˜çš„æ¶ˆé™¤ï¼Œä»è€Œå¯¼è‡´æ›´é«˜çš„ç³»ç»Ÿæ€§è¯ç‰©æš´éœ²é‡ã€‚[\[27\]](#cite_note-rxlist-27)

å°½ç®¡è«è¾¾éå°¼å¯èƒ½ä¼šå¼•èµ·æ¶å¿ƒå’Œé…¸åæµï¼Œä½†ä¸åº”ä¸å¥¥ç¾æ‹‰å”‘ï¼ˆä¸€ç§ CYP2C19 åº•ç‰©ï¼‰ä¸€èµ·æœç”¨ã€‚[\[27\]](#cite_note-rxlist-27)

## æ³•å¾‹åœ°ä½

è«è¾¾éå°¼åœ¨ä¸–ç•ŒèŒƒå›´å†…è¢«åˆæ³•æ‰¹å‡†ç”¨äºåŒ»ç–—ç›®çš„ã€‚ç„¶è€Œï¼Œåœ¨å¤§å¤šæ•°å›½å®¶ï¼Œæ²¡æœ‰å¤„æ–¹å‡ºå”®å’Œæ‹¥æœ‰å®ƒæ˜¯éæ³•çš„ã€‚

*   **æ¾³å¤§åˆ©äºšï¼š** è«è¾¾éå°¼åœ¨æ¾³å¤§åˆ©äºšè¢«åˆ—ä¸ºé™„è¡¨ 4ï¼ˆä»…é™å¤„æ–¹ï¼‰è¯ç‰©ï¼Œå¯ç”¨äºæ²»ç–—ç¡çœ å‘¼å¸æš‚åœå’Œå‘ä½œæ€§ç¡ç—…ã€‚[\[28\]](#cite_note-28)
*   **å¥¥åœ°åˆ©ï¼š** è«è¾¾éå°¼è¢«å½’ç±»ä¸º NRï¼ˆä»…é™å¤„æ–¹ï¼Œç¦æ­¢é‡å¤é…è¯ï¼‰ [\[29\]](#cite_note-29)
*   **åŠ æ‹¿å¤§ï¼š** è«è¾¾éå°¼åœ¨åŠ æ‹¿å¤§è¢«åˆ—ä¸ºé™„è¡¨ F å¤„æ–¹è¯ï¼Œå¯ç”¨äºäººç±»å’Œå…½åŒ»ç”¨é€”ã€‚[\[30\]](#cite_note-30)
*   **å¾·å›½ï¼š** æ ¹æ® Anlage 1 AMVVï¼Œè«è¾¾éå°¼æ˜¯ä¸€ç§å¤„æ–¹è¯ã€‚[\[31\]](#cite_note-31)
*   **ä¿„ç½—æ–¯è”é‚¦ï¼š** è«è¾¾éå°¼è¢«å½’ç±»ä¸ºé™„è¡¨ II ç‰©è´¨ã€‚ [\[32\]](#cite_note-32)
*   **ç‘å£«ï¼š** è«è¾¾éå°¼è¢«åˆ—ä¸ºâ€œAbgabekategorie Bâ€è¯ç‰©ï¼Œéœ€è¦å¤„æ–¹ã€‚\[*[æ¥æºè¯·æ±‚](../æ–‡æ¡£/æ¥æºè¯·æ±‚.md)*\]
*   **è‹±å›½ï¼š** è«è¾¾éå°¼åœ¨è‹±å›½æ˜¯ä¸€ç§è·å¾—è®¸å¯çš„ä»…é™å¤„æ–¹è¯ç‰© (POM)ã€‚[\[33\]](#cite_note-33) åœ¨æ²¡æœ‰æœ‰æ•ˆå¤„æ–¹çš„æƒ…å†µä¸‹æ‹¥æœ‰è¿™ç§è¯ç‰©å¹¶ä¸æ„æˆåˆ‘äº‹çŠ¯ç½ªã€‚æ ¹æ® 1968 å¹´è¯å“æ³•ç¬¬ 13 æ¡çš„è§„å®šï¼Œå¯ä»¥é€šè¿‡æœ‰æ•ˆå¤„æ–¹æˆ–åˆæ³•è¿›å£ä¾›ä¸ªäººä½¿ç”¨çš„è¯ç‰©æ¥åˆæ³•è·å¾—è¯¥è¯ç‰©ã€‚[\[34\]](#cite_note-34)
*   **ç¾å›½ï¼š** åœ¨ç¾å›½ï¼Œè«è¾¾éå°¼æ˜¯é™„è¡¨ IV ç®¡åˆ¶ç‰©è´¨ã€‚åœ¨æ²¡æœ‰å¤„æ–¹æˆ– DEA æ‰§ç…§çš„æƒ…å†µä¸‹è´­ä¹°ã€å‡ºå”®æˆ–æ‹¥æœ‰è¯¥è¯ç‰©æ˜¯éæ³•çš„ã€‚[\[35\]](#cite_note-35)

## å¦è§

*   [è´Ÿè´£ä»»çš„ç”¨è¯](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)
*   [ç›Šæ™ºè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç›Šæ™ºè¯.md)
*   [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)
*   [é˜¿è«è¾¾éå°¼](../è¯ç‰©/é˜¿è«è¾¾éå°¼.md)
*   [å’–å•¡å› ](../è¯ç‰©/å’–å•¡å› .md)

## å¤–éƒ¨é“¾æ¥

*   [Modafinil (Wikipedia)](http://en.wikipedia.org/wiki/Modafinil)
*   [Modafinil (Erowid Vault)](https://www.erowid.org/smarts/modafinil/)
*   [Modafinil (Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=2978)
*   [Modafinil (DrugBank)](https://go.drugbank.com/drugs/DB00745)
*   [Modafinil (Drugs-Forum)](https://drugs-forum.com/wiki/Modafinil)

## å‚è€ƒæ–‡çŒ®

1.  [â†‘](#cite_ref-1) Provigal (Manufacturer's Website) \| <http://www.provigil.com/>
2.  [â†‘](#cite_ref-2) Fava, M., Thase, M. E., DeBattista, C., Doghramji, K., Arora, S., Hughes, R. J. (September 2007). "Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness". *Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists*. **19** (3): 153â€“159. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1080/10401230701464858](//doi.org/10.1080%2F10401230701464858). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1040-1237](//www.worldcat.org/issn/1040-1237).Â 
3.  [â†‘](#cite_ref-3) Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., Walden, J., Leverich, G. S., Altshuler, L. L., Nakelsky, S., Hwang, S., Mintz, J., Post, R. M. (August 2007). "A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression". *The American Journal of Psychiatry*. **164** (8): 1242â€“1249. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/appi.ajp.2007.06060981](//doi.org/10.1176%2Fappi.ajp.2007.06060981). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0002-953X](//www.worldcat.org/issn/0002-953X).Â 
4.  [â†‘](#cite_ref-4) Vliet, S. A. M. van, Vanwersch, R. A. P., Jongsma, M. J., Gugten, J. van der, Olivier, B., Philippens, I. H. C. H. M. (September 2006). "Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects". *Behavioural Pharmacology*. **17** (5â€“6): 453â€“462. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1097/00008877-200609000-00011](//doi.org/10.1097%2F00008877-200609000-00011). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0955-8810](//www.worldcat.org/issn/0955-8810).Â 
5.  [â†‘](#cite_ref-5) Lundt, L. (August 2004). "Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study". *Journal of Affective Disorders*. **81** (2): 173â€“178. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/S0165-0327(03)00162-9](//doi.org/10.1016%2FS0165-0327%2803%2900162-9). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0165-0327](//www.worldcat.org/issn/0165-0327).Â 
6.  [â†‘](#cite_ref-6) Biederman, J., Pliszka, S. R. (March 2008). "Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents". *The Journal of Pediatrics*. **152** (3): 394â€“399. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.jpeds.2007.07.052](//doi.org/10.1016%2Fj.jpeds.2007.07.052). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1097-6833](//www.worldcat.org/issn/1097-6833).Â 
7.  [â†‘](#cite_ref-7) <https://www.cyclingnews.com/news/clinger-given-two-year-suspension-for-doping>
8.  [â†‘](#cite_ref-8) <https://web.archive.org/web/20120122061356/http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html>
9.  [â†‘](#cite_ref-9) <https://journals.lww.com/acsm-msse/fulltext/2004/06000/effects_of_acute_modafinil_ingestion_on_exercise.23.aspx>
10. [â†‘](#cite_ref-10) <https://pubmed.ncbi.nlm.nih.gov/34632515>
11. [â†‘](#cite_ref-11) Ballas, C. A., Kim, D., Baldassano, C. F., Hoeh, N. (1 July 2002). ["Modafinil: past, present and future"](https://doi.org/10.1586/14737175.2.4.449). *Expert Review of Neurotherapeutics*. **2** (4): 449â€“457. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1586/14737175.2.4.449](//doi.org/10.1586%2F14737175.2.4.449). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1473-7175](//www.worldcat.org/issn/1473-7175).Â 
12. [â†‘](#cite_ref-12) De Risi, C., Ferraro, L., Pollini, G. P., Tanganelli, S., Valente, F., Veronese, A. C. (1 December 2008). ["Efficient synthesis and biological evaluation of two modafinil analogues"](https://www.sciencedirect.com/science/article/pii/S0968089608009772). *Bioorganic & Medicinal Chemistry*. **16** (23): 9904â€“9910. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.bmc.2008.10.027](//doi.org/10.1016%2Fj.bmc.2008.10.027). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0968-0896](//www.worldcat.org/issn/0968-0896).Â 
13. [â†‘](#cite_ref-13) Testdrugs (September 7, 2022). ["Modafinil Testdrugs.info Website"](https://app.testdrugs.info/substances/564). Testdrugs.Â 
14. â†‘ [14.0](#cite_ref-morrissette2013_14-0) [14.1](#cite_ref-morrissette2013_14-1) Morrissette, D. A. (December 2013). ["Twisting the night away: a review of the neurobiology, genetics, diagnosis, and treatment of shift work disorder"](https://www.cambridge.org/core/product/identifier/S109285291300076X/type/journal_article). *CNS Spectrums*. **18** (s1): 42â€“54. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1017/S109285291300076X](//doi.org/10.1017%2FS109285291300076X). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1092-8529](//www.worldcat.org/issn/1092-8529).Â 
15. [â†‘](#cite_ref-15) Touitou, Y., Bogdan, A. (February 2007). ["Promoting adjustment of the sleepâ€“wake cycle by chronobiotics"](https://linkinghub.elsevier.com/retrieve/pii/S0031938406003866). *Physiology & Behavior*. **90** (2â€“3): 294â€“300. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.physbeh.2006.09.001](//doi.org/10.1016%2Fj.physbeh.2006.09.001). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0031-9384](//www.worldcat.org/issn/0031-9384).Â 
16. â†‘ [16.0](#cite_ref-darwish2012_16-0) [16.1](#cite_ref-darwish2012_16-1) Darwish, M., Kirby, M., Dâ€™Andrea, D. M., Yang, R., Hellriegel, E. T., Robertson, P. (November 2010). ["Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study"](https://linkinghub.elsevier.com/retrieve/pii/S0149291810003711). *Clinical Therapeutics*. **32** (12): 2074â€“2087. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.clinthera.2010.11.009](//doi.org/10.1016%2Fj.clinthera.2010.11.009). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0149-2918](//www.worldcat.org/issn/0149-2918).Â 
17. [â†‘](#cite_ref-17) Erman, M. K., Yang, R., Seiden, D. J. (2012). "The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial". *The primary care companion for CNS disorders*. **14** (4): PCC.12m01345. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.4088/PCC.12m01345](//doi.org/10.4088%2FPCC.12m01345). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [2155-7772](//www.worldcat.org/issn/2155-7772).Â 
18. [â†‘](#cite_ref-18) He, B., Peng, H., Zhao, Y., Zhou, H., Zhao, Z. (December 2011). ["Modafinil treatment prevents REM sleep deprivation-induced brain function impairment by increasing MMP-9 expression"](https://linkinghub.elsevier.com/retrieve/pii/S0006899311016581). *Brain Research*. **1426**: 38â€“42. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.brainres.2011.09.002](//doi.org/10.1016%2Fj.brainres.2011.09.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0006-8993](//www.worldcat.org/issn/0006-8993).Â 
19. [â†‘](#cite_ref-19) Udert, K. M., Larsen, T. A., Gujer, W. (1 December 2006). ["Fate of major compounds in source-separated urine"](https://iwaponline.com/wst/article/54/11-12/413/13916/Fate-of-major-compounds-in-sourceseparated-urine). *Water Science and Technology*. **54** (11â€“12): 413â€“420. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.2166/wst.2006.921](//doi.org/10.2166%2Fwst.2006.921). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0273-1223](//www.worldcat.org/issn/0273-1223).Â 
20. [â†‘](#cite_ref-20) Banerjee, D., Vitiello, M. V., Grunstein, R. R. (1 October 2004). ["Pharmacotherapy for excessive daytime sleepiness"](https://www.sciencedirect.com/science/article/pii/S1087079204000243). *Sleep Medicine Reviews*. **8** (5): 339â€“354. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.smrv.2004.03.002](//doi.org/10.1016%2Fj.smrv.2004.03.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1087-0792](//www.worldcat.org/issn/1087-0792).Â 
21. [â†‘](#cite_ref-21) The National Library of Medicine - PROVIGIL \| <http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd75a8a7-a8ab-4141-9af9-989a220b9c19>
22. [â†‘](#cite_ref-22) Neuman, G., Shehadeh, N., Pillar, G. (15 August 2009). ["Unsuccessful Suicide Attempt of a 15 Year Old Adolescent with Ingestion of 5000 mg Modafinil"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725258/). *Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine*. **5** (4): 372â€“373. [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1550-9389](//www.worldcat.org/issn/1550-9389).Â 
23. [â†‘](#cite_ref-23) Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009). "Dose-independent occurrence of seizure with tramadol". *Journal of Medical Toxicology*. **5** (2): 63â€“67. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1007/BF03161089](//doi.org/10.1007%2FBF03161089). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number")Â [1937-6995](//www.worldcat.org/issn/1937-6995). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1556-9039](//www.worldcat.org/issn/1556-9039). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC")Â [163567183](//www.worldcat.org/oclc/163567183).Â 
24. [â†‘](#cite_ref-24) Gillman, P. K. (2005). ["Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity"](https://bjanaesthesia.org/article/S0007-0912(17)34956-5/fulltext). *British Journal of Anaesthesia*. **95** (4): 434â€“441. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/bja/aei210](//doi.org/10.1093%2Fbja%2Faei210)â€¯![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number")Â [1471-6771](//www.worldcat.org/issn/1471-6771). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0007-0912](//www.worldcat.org/issn/0007-0912). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC")Â [01537271](//www.worldcat.org/oclc/01537271). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier")Â [16051647](//www.ncbi.nlm.nih.gov/pubmed/16051647).Â 
25. [â†‘](#cite_ref-25) Robertson, P (2002). "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers". *Clinical Pharmacology & Therapeutics*. Springer Nature. **71** (1): 46â€“56. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1067/mcp.2002.121217](//doi.org/10.1067%2Fmcp.2002.121217). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0009-9236](//www.worldcat.org/issn/0009-9236).Â 
26. [â†‘](#cite_ref-26) Bailey, D. G.; Dresser, G.; Arnold, J. M. O. (2012-11-26). "Grapefruit-medication interactions: Forbidden fruit or avoidable consequences?". *Canadian Medical Association Journal*. Joule Inc. **185** (4): 309â€“316. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1503/cmaj.120951](//doi.org/10.1503%2Fcmaj.120951). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0820-3946](//www.worldcat.org/issn/0820-3946).Â 
27. â†‘ [27.0](#cite_ref-rxlist_27-0) [27.1](#cite_ref-rxlist_27-1) <https://www.rxlist.com/provigil-drug.htm>
28. [â†‘](#cite_ref-28) [*Modafinil*](https://en.wikipedia.org/w/index.php?title=Modafinil&oldid=1100020692)Â 
29. [â†‘](#cite_ref-29) Rezeptverordnung \| <https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358>
30. [â†‘](#cite_ref-30) National Association of Pharmacy Regulatory Authorities - Regulations Amending the Food and Drug Regulations (1184 â€” Modafinil) \| <http://napra.ca/Content_Files/Files/FDR-Project1184-Modafinil-Oct122006.pdf>
31. [â†‘](#cite_ref-31) [*AMVV - Verordnung Ã¼ber die Verschreibungspflicht von Arzneimitteln*](https://www.gesetze-im-internet.de/amvv/BJNR363210005.html)Â 
32. [â†‘](#cite_ref-32) ["Narcotics"](http://www.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=142882;fld=134;dst=4294967295;rnd=0.8965571122244;from=141820-563).Â 
33. [â†‘](#cite_ref-33) MHRA (April 3, 2013). ["MHRA license for Modafinil in UK"](http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con273748.pdf) (PDF). MHRA.Â 
34. [â†‘](#cite_ref-34) ["Medicines Act 1968 Section 13"](http://www.legislation.gov.uk/ukpga/1968/67/section/13).Â 
35. [â†‘](#cite_ref-35) Placement of Modafinil Into Schedule IV - U.S. Department of Justice \| <http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0127.htm>